Implementation and use of risk minimization control tools in the EU: A multistakeholder survey.

Uptravi (selexipag) - J&J

lenalidomide - Generic mfg.

Fintepla (low-dose fenfluramine) - UCB

Strimvelis (autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence) - Kyowa Kirin

Spravato (esketamine intranasal) - J&J

Soliris (eculizumab) - AstraZeneca

Yescarta (axicabtagene ciloleucel) - Gilead

http://www.ncbi.nlm.nih.gov/pubmed/42648741

Christina E Hoeve; Christine Leopold; Christos Kontogiorgis; Dimitra Tsioumela; Elena Deligianni; Elita Poplavska; Ella D van Vliet; Emelie Karlsson; Iluta Ž?gure; Iris R Joosse; Juan Erviti; Luis Carlos Saiz; Marie L De Bruin; Marta Gutiérrez-Valencia; Maximilian Salcher-Konrad; Melanie Walter; Mitja Kos; Renato Ferreira-da-Silva; Sharon C M Essink; Sofia Kälvemark Sporrong; Teresa Leonardo Alves

Aug 27, 2026